Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  648,328 results for ""MYELOID leukemia""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia.

  • Authors : Benesova A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.; De Santis S

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics ; Leukemia, Myeloid*; Humans

  • Source: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 759-762. Date of Electronic Publication: 2024 Feb 05.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript.

  • Authors : Dereme J; Service and Central Laboratory of Haematology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Voruz S

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics ; Leukemia, Myeloid*

  • Source: Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 1027-1029. Date of Electronic Publication: 2024 Jan 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of HLA-E single nucleotide polymorphisms with human myeloid leukemia.

  • Authors : Sun L; Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.; Shenzhen Institution of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China.

Subjects: Polymorphism, Single Nucleotide* ; Leukemia, Myeloid*/Leukemia, Myeloid*/Leukemia, Myeloid*/genetics; Humans

  • Source: HLA [HLA] 2024 Apr; Vol. 103 (4), pp. e15440.Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101675570 Publication Model: Print Cited Medium: Internet ISSN: 2059-2310

Record details

Read More Add to Saved list
×
Academic Journal

FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.

  • Authors : Takeda K; Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.; Ohta S

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics ; Leukemia, Myeloid*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 26; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach.

  • Authors : Menger JM; Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, 10069, USA. .; Sathianathen RS

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics ; Leukemia, Myeloid*

  • Source: Current oncology reports [Curr Oncol Rep] 2024 Mar; Vol. 26 (3), pp. 250-257. Date of Electronic Publication: 2024 Feb 10.Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia

  • Authors : Tokatlı M; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Türkiye; Ismayilov R

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/complications ; Leukemia, Myeloid*/Leukemia, Myeloid*/Leukemia, Myeloid*/complications

  • Source: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 59-60. Date of Electronic Publication: 2023 Dec Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Effect of TRIM59 Expression Interference on Daunorubicin Chemosensitivity of Chronic Myeloid Leukemia K562 Cells and Its Mechanism].

  • Authors : Wang J; Department of Basic Medicine, Puyang Medical College, Puyang 457000 Henan Province, China.E-mail: .; Wang ZJ

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive* ; Leukemia, Myeloid*; Humans

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Feb; Vol. 32 (1), pp. 45-51.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.

  • Authors : Žáčková D; Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic. .; Semerád L

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myeloid*; Humans

  • Source: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 893-897. Date of Electronic Publication: 2024 Mar 12.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.

  • Authors : Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy. .; Scaffidi L

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive* ; Leukemia, Myeloid*; Humans

  • Source: Blood cancer journal [Blood Cancer J] 2024 Mar 26; Vol. 14 (1), pp. 53. Date of Electronic Publication: 2024 Mar 26.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy.

  • Authors : Liu Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, P. R. China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P. R. China.

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/therapy ; Leukemia, Myeloid*; Humans

  • Source: Blood cancer journal [Blood Cancer J] 2024 Mar 06; Vol. 14 (1), pp. 39. Date of Electronic Publication: 2024 Mar 06.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  648,328 results for ""MYELOID leukemia""